Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Orforglipron for Sale > US API powder Orforglipron Powder
US API powder Orforglipron Powder buy - large image1
US API powder Orforglipron Powder buy - image1
US API powder Orforglipron Powder buy - image2
US API powder Orforglipron Powder buy - image3
US API powder Orforglipron Powder buy - image4
US API powder Orforglipron Powder buy - image5
US API powder Orforglipron Powder buy - image6

US API powder Orforglipron Powder

GMP ISO 26 Inquiries

Unit Price: Get Latest Price
CAS No.:

2212020-52-3

Content:

99%

Port:

Beijing

Packaging:

Bag

Price valid (until):

2025-09-04

Company Type:
Trader
Location:
Hongkong, China
Qualification:
Main Products:

Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Introduction


    Product Description
    Product name Orforglipron
    CAS number 2212020-52-3
    Molecular formula //
    Molecular weight //
    Purity ≥99%
    Appearance White Powder
    Grade Medical Grade
    MOQ 1 gram
    Function weight loss

    GLP-1 receptor agonist 1  were approved by the FDA for weight loss in late 2014. It's a newer class of drugs better known for its ability to improve blood sugar control. These medications were actually designed to treat type II diabetes, but some have also been FDA approved to treat weight loss


    Application

    • Helps slow food leaving your stomach
    • Helps prevent your liver from making too much sugar
    • Helps the pancreas produce more insul when your blood sugar levels are high
    • Can help control blood glucose
    • Can reduce hyperglycemia, especially after meals
    • Can reduce fasting insul and fasting glucose
    • Can reduce hemoglobin A1c
    • Can decrease appetite and caloric intake, while inhibiting weight gain
    • Has been shown to lower triglyceride levels and oxidative stress from high LDL
    • Has been shown to help induce weight loss in obese patients with higher dosing
    • Helps decrease leptin and increase leptin sensitivity
    • Can increase the conversion of white fat to brown fat
      Peptide: A New Hope for Obesity Treatment
      Obesity is a complex metabolic disorder that affects millions of people worldwide. It is associated with various health risks including cardiovascular diseases, diabetes, and some forms of cancer. Despite the development of several weight-loss strategies, the number of obese people continues to rise. This prompts the need for new and effective anti-obesity drugs. One such promising drug is peptide Trizepatide.
      Peptides are short chains of amino acids that have biological functions in the body. Trizepatide is a novel peptide that acts on three targets: the glucagon-like peptide-1 (GLP-1) receptor, the gastric inhibitory peptide (GIP) receptor, and the glucagon receptor. These receptors are involved in the regulation of glucose and energy metabolism in the body. By activating these receptors, can increase secretion,decrease appetite, and promote fat burning.

    Orforglipron is the newest GLP-1R agonist and was approved by the FDA as a once-weekly injection for the treatment of T2DM in late 2017. The peptide is chemically similar to liraglutide, with the inclusion of two structural modifications (Lau, Bloch, et al., 2015). The first is the replacement of Gly with the non-proteinogenic amino acid 2-aminoisobutyric acid (Aib) at position 2. The second is the attachment of octadecanoic diacid to the side chain of Lys-26 through a short polyethylene glycol (PEG) spacer and a γ-glutamic acid linker. The amino acid substitution renders the peptide more resistant to DPP-4 compared to liraglutide, and the presence of the 18-carbon fatty acid moiety results in a high binding affinity for serum albumin, which translates to a half-life of approximately 7 days in humans

    Shop GLP-1 Raw Powder Orforglipron (LY-3502970) Peptides Orforglipron-Detailed Image 1

    Q1: When will the product be shipped after payment?
      ---We are committed to the same day shipping.

    Q2. How does your factory control quality?
    All the raw material purchasing and production quality control are strictly following the ISO9001: 2008 management system. Besides, the full-featured detection equipment and GMP quality management system provided the strongest guarantee for a high-quality product.


    Q3: How long will it take to receive the parcel?
       --3 days for the US market; 4-6 days for the others.

    Q4: What can I do if I don't have the ability to clear the custom?
       --We got experience after doing export for many years, so don't worry we can handle that.

    Q5: Can I get some samples?
       ---Yes.
     

    Contact us if you want to order online.

    Certificates

    Basic Info
    Product Name:

    Orforglipron

    Other Name:

    1,2,4-Oxadiazol-5(2H)-one, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcy...;LY3502970;GLP-1 receptor agonist 1 USP/EP/BP;Orforglipron;Orforglipron(LY3502970);LY3502970 (Orforglipron);3-((1S,2S)-1-(5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one;OWL 833

    CAS No.:

    2212020-52-3

    Molecular Formula:

    C48H48F2N10O5

    InChIKeys:

    USUWIEBBBWHKNI-BBGRWQLENA-N

    Molecular Weight:

    882.97

    EC Number:

    278-636-5

    Color/Form:

    Off-white to light yellow

    Categories:

    Polypeptide

    Characteristics
    Density:

    1.50±0.1 g/cm3(Predicted)

    PKA:

    7.33±0.20(Predicted)

    Critical Temperature & Pressure:

    Store at -20°C

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

    Location:

    Unit D01,3/F., Wong King Industrial Building,No.2 Tai Yau Street, Kowloon

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    51-100

    Year of Establishment:

    2012

    We have more than 10 years experience in the pharmacy filed. Mainly manufactures pharmaceutical APIs,Pharmaceutical intermediate and Cosmetic raw material. Owing to the good quality and competitive price, we have a very good reputation in China's pharmaceutical circles.

    In the principle of "Quality Oriented", Jianfeng passed the certification of ISO9001:2008 Quality Management System.

    Our products are based on bulk, high volume, wholesale price, third party testing, certificate reporting, and bring high quality ingredients to many domestic and overseas enterprises.

    "Honesty, practicality, innovation, development" are our values. Jianfeng would like to cooperate with you with high quality products and competitive price.

  • Inquiry History
    26 Inquiries
    Country Product Purchase Quantity Date Posted
    Bulgaria

    orforglipron

    1 KG Aug 27, 2025
    Austria

    Orforglipron

    1000 MT Jun 12, 2026
    Switzerland

    Orforglipron

    10 MG Apr 25, 2026
    United States

    Orforglipron

    20 G Apr 3, 2026
    United States

    Orforglipron

    10 G Mar 29, 2026
    United States

    oforglipron

    3 KG Jul 4, 2025
    Belgium

    Orforglipron

    1 G Jun 14, 2026
    Puerto Rico

    Orforglipron

    1 G Mar 2, 2026
    United States

    Orforglipron

    10 G Oct 24, 2025
    United States

    Orforglipron

    1 G Sep 30, 2025
    United States

    Orforglipron

    1 G Sep 26, 2025
    United States

    Orforglipron

    1 G Sep 26, 2025
    United States

    orforglipron

    1 MT Sep 20, 2025
    United States

    Orforglipron

    1 KG Apr 18, 2025
    Canada

    LY-3502970

    10 G Feb 26, 2026
    United States

    Orforglipron

    200 PCS Jun 18, 2026
    United States

    orforglipron

    10 G Apr 20, 2026
    United States

    Orforglipron

    10 G Apr 6, 2026
    United States

    orforglipron

    1 G Mar 24, 2026
    Germany

    Orforglipron

    2 G Mar 23, 2026
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.